Related Experiment Video
Updated: Jun 18, 2025
06:15
Author Spotlight: Anterior HR-OCT as a Non-Invasive Tool for Characterizing Ocular Surface Squamous Neoplasia
Published on: August 9, 2024
1.2K
Epithelioid hemangioendothelioma: a case report
Sat Byul Park1, Young Bae Kim2, Seulgi You3
1Department of Family Practice and Community Health, Ajou University School of Medicine, Suwon, Korea.
AME Case Reports
|August 2, 2024
Summary
Epithelioid hemangioendothelioma (EHE) is a rare vascular tumor. This case highlights a patient with metastatic EHE who experienced a surprisingly indolent clinical course, emphasizing individualized treatment approaches.
Area of Science:
- Oncology
- Vascular Tumors
Background:
- Epithelioid hemangioendothelioma (EHE) is a rare vascular neoplasm with variable clinical behavior.
- Diagnosis relies on histological, immunohistochemical, and molecular features, with autoimmune diseases as differential diagnoses.
- Treatment options include surgery, transplantation, chemotherapy, and radiotherapy.
Observation:
- A case of hepatic EHE presenting with weight loss and weakness is described.
- The patient's EHE metastasized to the lungs and brain.
- Histopathology confirmed EHE, with specific immunohistochemical markers (CK7 negative, CD34 positive).
Findings:
- Despite metastasis, the patient exhibited an unexpectedly indolent clinical course.
- Favorable prognosis factors included good general condition, absence of familial genetic factors, and normal tumor markers (alpha-fetoprotein, CEA).
Implications:
- The variable prognosis of EHE necessitates tailored treatment strategies based on individual patient status.
- This case underscores the importance of considering patient-specific factors in managing rare vascular tumors like EHE.
